Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

ANGO

Angiodynamic Inc

Apr 16 • 01:20PM ET

6.42

Dollar change +0.11
Percentage change 1.74	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN SCHA DFAT VTWO VHT PRFZ IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.78	Insider Own	3.56%	Shs Outstand	39.61M	Perf Week	-7.89%
Market Cap	257.12M	Forward P/E	-	EPS next Y	-0.49	Insider Trans	0.71%	Shs Float	38.63M	Perf Month	19.55%
Income	-192.37M	PEG	-	EPS next Q	-0.16	Inst Own	89.44%	Short Float	5.83%	Perf Quarter	8.08%
Sales	324.01M	P/S	0.79	EPS this Y	-783.33%	Inst Trans	-0.27%	Short Ratio	4.16	Perf Half Y	-2.28%
Book/sh	5.41	P/B	1.19	EPS next Y	6.60%	ROA	-44.34%	Short Interest	2.25M	Perf Year	-29.37%
Cash/sh	1.96	P/C	3.28	EPS next 5Y	15.00%	ROE	-62.42%	52W Range	5.26 - 11.38	Perf YTD	-18.11%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-87.04%	52W High	-43.59%	Beta	0.65
Dividend TTM	-	Quick Ratio	1.62	Sales past 5Y	5.40%	Gross Margin	45.57%	52W Low	22.05%	ATR (14)	0.37
Dividend Ex-Date	-	Current Ratio	2.29	EPS Y/Y TTM	-405.25%	Oper. Margin	-9.40%	RSI (14)	55.25	Volatility	4.88% 5.35%
Employees	815	Debt/Eq	0.02	Sales Y/Y TTM	-3.19%	Profit Margin	-59.37%	Recom	1.25	Target Price	13.50
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-1843.40%	Payout	-	Rel Volume	0.48	Prev Close	6.31
Sales Surprise	-11.06%	EPS Surprise	-3.23%	Sales Q/Q	-6.85%	Earnings	Apr 04 BMO	Avg Volume	540.56K	Price	6.42
SMA20	6.04%	SMA50	8.62%	SMA200	-9.32%	Trades		Volume	159,424	Change	1.74%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-05-24	Upgrade	Oppenheimer	Perform → Outperform	$12
Sep-25-23	Initiated	H.C. Wainwright	Buy	$19
Apr-17-23	Downgrade	Raymond James	Strong Buy → Outperform	$14 → $13
Oct-15-21	Upgrade	Canaccord Genuity	Hold → Buy	$28 → $37
Aug-20-21	Initiated	Oppenheimer	Perform
Nov-25-20	Upgrade	Raymond James	Mkt Perform → Strong Buy	$18
Apr-08-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-01-19	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Apr-03-18	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-05-18	Downgrade	Craig Hallum	Buy → Hold
Apr-07-17	Reiterated	Cantor Fitzgerald	Overweight	$20 → $21
Mar-30-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight
Feb-08-17	Initiated	Barclays	Equal Weight	$17
Nov-04-16	Initiated	Cantor Fitzgerald	Buy
Apr-08-16	Resumed	Piper Jaffray	Neutral
Jan-08-16	Reiterated	Canaccord Genuity	Buy	$17.50 → $14.50
Nov-10-15	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-24-15	Initiated	KeyBanc Capital Mkts	Overweight
Jun-19-14	Upgrade	Canaccord Genuity	Hold → Buy	$16.25 → $20
Oct-09-12	Reiterated	Canaccord Genuity	Hold	$14 → $13.50

Show Previous Ratings

Apr-08-24 09:26AM	AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript (Insider Monkey) -5.97%
Apr-05-24 11:52AM	AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates (Zacks) +9.84%
11:43AM	AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment (Zacks)
Apr-04-24 10:13PM	Q3 2024 AngioDynamics Inc Earnings Call (Thomson Reuters StreetEvents) +5.26%
02:53PM	Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars (Benzinga)
11:53AM	Loading…
11:53AM	ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024 (InvestorPlace)
08:51AM	AngioDynamics Inc (ANGO) Posts Q3 Fiscal 2024 Results: A Mixed Performance Amidst Asset Divestiture (GuruFocus.com)
07:11AM	AngioDynamics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture (Business Wire)
06:45AM	AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE (Business Wire)
Apr-02-24 10:32AM	AngioDynamics (ANGO) Settles Patent Litigations With BD (Zacks) +6.17%
Apr-01-24 05:26PM	AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc. (Business Wire)
Mar-28-24 10:00AM	Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Mar-19-24 04:01PM	AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024 (Business Wire)
Mar-15-24 06:15PM	AngioDynamics (ANGO) Declines More Than Market: Some Information for Investors (Zacks)
06:15PM	Loading…
Mar-08-24 06:15PM	Why AngioDynamics (ANGO) Dipped More Than Broader Market Today (Zacks)
Mar-06-24 04:01PM	AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference (Business Wire)
Mar-01-24 06:15PM	AngioDynamics (ANGO) Gains But Lags Market: What You Should Know (Zacks)
Feb-22-24 06:15PM	Here's Why AngioDynamics (ANGO) Gained But Lagged the Market Today (Zacks)
Feb-16-24 10:57AM	AngioDynamics (ANGO) Divests Its PICC & Midline Businesses (Zacks)
Feb-15-24 06:15PM	Why AngioDynamics (ANGO) Outpaced the Stock Market Today (Zacks)
04:05PM	AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million (Business Wire)
Feb-09-24 06:15PM	AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why (Zacks)
Jan-25-24 10:35AM	AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment (Zacks)
Jan-23-24 08:00AM	AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease (Business Wire)
Jan-08-24 10:17AM	AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss (Zacks)
08:29AM	AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2024 Earnings Call Transcript (Insider Monkey)
Jan-06-24 12:25AM	Q2 2024 AngioDynamics Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-05-24 03:35PM	Why AngioDynamics Stock Got Destroyed Today (Motley Fool) -19.87%
02:13PM	AngioDynamics Inc (ANGO) Reports Fiscal 2024 Second Quarter Results and Revises Full-Year Guidance (GuruFocus.com)
12:51PM	Loading…
12:51PM	ANGO Stock Earnings: AngioDynamics Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
12:20PM	Greenbrier, Constellation Brands rise; AngioDynamics, Agilon Health fall, Friday, 1/5/2024 (Associated Press Finance)
08:10AM	AngioDynamics (ANGO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:24AM	AngioDynamics Q2 Results Miss Estimates; Boosts FY24 Adj. EPS Outlook (RTT News)
07:09AM	AngioDynamics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance (Business Wire)
Dec-29-23 10:00AM	Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Dec-21-23 04:01PM	AngioDynamics to Present at the J.P. Morgan Healthcare Conference (Business Wire)
Dec-19-23 06:15PM	Why AngioDynamics (ANGO) Outpaced the Stock Market Today (Zacks)
Dec-11-23 06:15PM	AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Dec-07-23 04:01PM	AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024 (Business Wire)
08:00AM	AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism (Business Wire)
Dec-04-23 06:15PM	AngioDynamics (ANGO) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Nov-28-23 06:15PM	AngioDynamics (ANGO) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Nov-22-23 06:15PM	AngioDynamics (ANGO) Outperforms Broader Market: What You Need to Know (Zacks)
Nov-16-23 06:15PM	AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Nov-10-23 06:15PM	AngioDynamics (ANGO) Advances But Underperforms Market: Key Facts (Zacks)
Oct-06-23 09:00AM	Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
Oct-05-23 10:45AM	AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates (Zacks)
08:18AM	AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2024 Earnings Call Transcript (Insider Monkey)
Oct-04-23 11:51PM	Q1 2024 AngioDynamics Inc Earnings Call (Thomson Reuters StreetEvents)
06:15PM	Why Angiodynamics Stock Sank Today (Motley Fool)
12:24PM	AngioDynamics Inc (ANGO) Reports Strong Q1 2024 Performance, Reaffirms Fiscal Year 2024 Guidance (GuruFocus.com)
08:15AM	AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:13AM	AngioDynamics: Fiscal Q1 Earnings Snapshot (AP Finance)
07:00AM	AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance (Business Wire)
Sep-27-23 10:00AM	Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Sep-25-23 01:21PM	Why AngioDynamics Stock Popped on Monday (Motley Fool)
Sep-12-23 04:01PM	AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023 (Business Wire)
Sep-07-23 06:15PM	AngioDynamics (ANGO) Dips More Than Broader Markets: What You Should Know (Zacks)
Sep-01-23 06:51PM	Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Aug-29-23 06:15PM	AngioDynamics (ANGO) Outpaces Stock Market Gains: What You Should Know (Zacks)
Aug-23-23 06:15PM	AngioDynamics (ANGO) Stock Sinks As Market Gains: What You Should Know (Zacks)
Aug-17-23 06:15PM	AngioDynamics (ANGO) Flat As Market Sinks: What You Should Know (Zacks)
Aug-16-23 11:08AM	AngioDynamics' (ANGO) New FDA Recognition to Boost Treatment (Zacks)
Aug-15-23 04:01PM	AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation (Business Wire)
Aug-11-23 06:15PM	AngioDynamics (ANGO) Gains As Market Dips: What You Should Know (Zacks)
Aug-03-23 08:00AM	AngioDynamics Completes Enrollment for PRESERVE Clinical Study (Business Wire)
Jul-31-23 04:01PM	AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference (Business Wire)
Jul-25-23 09:53AM	Should Growth Investors Buy This Revolutionary Small-Cap Stock? (Motley Fool)
Jul-24-23 04:01PM	AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors (Business Wire)
Jul-14-23 12:07AM	AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Jul-13-23 11:59AM	AngioDynamics (ANGO) Q4 Earnings Lag Estimates, Revenues Top (Zacks)
12:12AM	Q4 2023 AngioDynamics Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-12-23 10:29AM	Why Are AngioDynamics Shares Trading Lower Today (Benzinga)
08:25AM	AngioDynamics (ANGO) Lags Q4 Earnings Estimates (Zacks)
07:22AM	AngioDynamics: Fiscal Q4 Earnings Snapshot (AP Finance)
07:00AM	AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance (Business Wire)
Jul-11-23 11:52AM	AngioDynamics (ANGO) to Report Q4 Earnings: What's in the Cards? (Zacks)
Jul-05-23 10:00AM	AngioDynamics (ANGO) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) -6.01%
Jul-03-23 12:20PM	Simulations Plus (SLP) to Report Q3 Earnings: What's in Store? (Zacks)
Jun-21-23 08:00PM	ANGO: What does Argus have to say about ANGO? (Argus Research)
10:09AM	Are Options Traders Betting on a Big Move in AngioDynamics (ANGO) Stock? (Zacks)
Jun-20-23 04:01PM	AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023 (Business Wire)
Jun-09-23 02:56PM	Why Shares of AngioDynamics Rose Friday (Motley Fool) +8.01%
Jun-08-23 04:01PM	AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million (Business Wire)
May-18-23 07:39AM	New Strong Sell Stocks for May 18th (Zacks)
May-16-23 09:12AM	Zacks.com featured highlights include Dutch Bros, Chegg, Impinj and AngioDynamics (Zacks)
May-15-23 09:41AM	Is the Options Market Predicting a Spike in AngioDynamics (ANGO) Stock? (Zacks)
08:59AM	Sell These 4 Toxic Stocks to Prevent Portfolio Losses (Zacks)
Apr-26-23 08:00PM	ANGO: What does Argus have to say about ANGO? (Argus Research)
Apr-17-23 08:29AM	Zacks.com featured highlights include AngioDynamics, Definitive Healthcare, Casella Waste Systems and Enviva (Zacks)
Apr-14-23 09:17AM	4 Toxic Stocks That Are Detrimental to Your Portfolio's Health (Zacks)
Apr-11-23 04:01PM	AngioDynamics to Present at the Needham Virtual Healthcare Conference (Business Wire)
Apr-10-23 08:30AM	Implied Volatility Surging for AngioDynamics (ANGO) Stock Options (Zacks)
Apr-04-23 09:53AM	Wall Street Thinks This Small-Cap Stock Can Double in Value (Motley Fool)
Apr-01-23 12:09PM	AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2023 Earnings Call Transcript (Insider Monkey)
Mar-31-23 07:38PM	AngioDynamics (ANGO) Q3 Earnings Lag Estimates, FY23 View Cut (Zacks) +13.63%
Mar-30-23 08:15AM	AngioDynamics (ANGO) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -27.02%
07:00AM	AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance (Business Wire)

AngioDynamics, Inc. operates as a medical device company, which engages in the development, manufacturing and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It operates through the Med Tech and Med Device segments. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Clemmer James C	President and CEO	Apr 08 '24	Buy	6.70	10,000	67,000	539,066	Apr 08 04:30 PM
Trowbridge Stephen A	EVP and CFO	Jul 19 '23	Option Exercise	0.00	8,769	0	123,364	Jul 26 09:32 PM
Centea Scott	SVP/GM, VIT	Jul 19 '23	Option Exercise	0.00	3,415	0	61,543	Jul 26 09:32 PM
Campbell Chad Thomas	SVP/GM, Vascular Access	Jul 19 '23	Option Exercise	0.00	3,900	0	51,409	Jul 26 09:32 PM
Helsel Dave	SVP Global Operations and R&D	Jul 19 '23	Option Exercise	0.00	4,371	0	32,660	Jul 26 09:32 PM
Clemmer James C	President and CEO	Jul 19 '23	Option Exercise	0.00	31,572	0	560,638	Jul 26 09:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ANGO

Angiodynamic Inc

Upgrade your FINVIZ experience